Balaxi Pharmaceuticals Ltd (BALAXI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 999933,
    "name": "Balaxi Pharma",
    "stock_name": "Balaxi Pharma",
    "full_name": "Balaxi Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/balaxi-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "24.49",
    "chg": 0.09,
    "chgp": "0.37%",
    "dir": 1,
    "prev_price": "24.40",
    "mcapval": "134.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "BALAXI",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE618N01022",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": 12648,
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/balaxi-pharma-999933-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Balaxi Pharmaceuticals Ltd Locks at Lower Circuit With 4.98% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/balaxi-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3996936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalaxiPharmaceu_stocks_hitting_lower_circuit_3996936.png",
        "date": "2026-05-18 11:00:17",
        "description": "At Rs 24.59, sellers were still queuing — but there were no buyers willing to take the other side. Balaxi Pharmaceuticals Ltd locked at its lower circuit of 4.98% on 18 May 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd Locks at Lower Circuit With 4.16% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/balaxi-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3985579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalaxiPharmaceu_stocks_hitting_lower_circuit_3985579.png",
        "date": "2026-05-11 11:00:11",
        "description": "At Rs 28.41, sellers were still queuing — but there were no buyers willing to take the other side. Balaxi Pharmaceuticals Ltd locked at its lower circuit of 5% on 11 May 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/balaxi-pharmaceuticals-ltd-is-rated-sell-3983912",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalaxiPharmaceu_mojoScore_3983912.png",
        "date": "2026-05-10 10:10:37",
        "description": "Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd Locks at Upper Circuit With 3.6% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/balaxi-pharmaceuticals-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3979732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalaxiPharmaceu_stocks_hitting_upper_circuit_3979732.png",
        "date": "2026-05-07 11:00:12",
        "description": "At Rs 28.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Balaxi Pharmaceuticals Ltd locked at its upper circuit of 3.6% on 7 May 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/balaxi-pharmaceuticals-ltd-is-rated-sell-3967983",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalaxiPharmaceu_mojoScore_3967983.png",
        "date": "2026-04-29 10:10:53",
        "description": "Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/balaxi-pharmaceuticals-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-3956125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalaxiPharmaceu_stocks_hitting_upper_circuit_3956125.png",
        "date": "2026-04-21 14:00:08",
        "description": "At Rs 28.00, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Balaxi Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 21 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/balaxi-pharmaceuticals-ltd-is-rated-sell-3951875",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalaxiPharmaceu_mojoScore_3951875.png",
        "date": "2026-04-18 10:10:38",
        "description": "Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 April 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/balaxi-pharmaceuticals-ltd-is-rated-sell-3934857",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalaxiPharmaceu_mojoScore_3934857.png",
        "date": "2026-04-07 10:10:45",
        "description": "Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Balaxi Pharmaceuticals Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/balaxi-pharmaceuticals-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3929047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalaxiPharmaceu_stocks_hitting_upper_circuit_3929047.png",
        "date": "2026-04-01 12:00:13",
        "description": "At Rs 18.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Balaxi Pharmaceuticals Ltd locked at its upper circuit of 19.97% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 107,
    "sid": "999933",
    "stock_news_url": "https://www.marketsmojo.com/news/balaxi-pharmaceuticals-999933"
  },
  "announcements": [
    {
      "details": "Balaxi Ventures Limited has informed the Exchange regarding Resignation of Mr Nidhin Jose as Chief Financial Officer of the company w.e.f. November 30, 2019.",
      "source": "NSE",
      "caption": "Balaxi Ventures Limited - Resignation",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Balaxi Ventures Limited has informed the Exchange regarding Statement of deviation(s) or variation(s) under Reg. 32 of SEBI (LODR) Regulations 2015",
      "source": "NSE",
      "caption": "Balaxi Ventures Limited - Statement of deviation(s) or variation(s) under Reg. 32",
      "datetime": "30-Oct-2019"
    },
    {
      "details": "Balaxi Ventures Limited has informed the Exchange regarding Board meeting held on October 29, 2019.",
      "source": "NSE",
      "caption": "Balaxi Ventures Limited - Outcome of Board Meeting",
      "datetime": "29-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "28 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Balaxi Pharmaceuticals Ltd has declared <strong>5%</strong> dividend, ex-date: 01 Jul 22",
          "dt": "2022-07-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Balaxi Pharmaceuticals Ltd has announced <strong>2:10</strong> stock split, ex-date: 30 May 24",
          "dt": "2024-05-30",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Balaxi Pharmaceuticals Ltd Locks at Lower Circuit With 4.98% Loss — Sellers Queue, No Buyers in Sight

2026-05-18 11:00:17

At Rs 24.59, sellers were still queuing — but there were no buyers willing to take the other side. Balaxi Pharmaceuticals Ltd locked at its lower circuit of 4.98% on 18 May 2026, with unfilled sell orders and a frozen price.

Read full news article

Balaxi Pharmaceuticals Ltd Locks at Lower Circuit With 4.16% Loss — Sellers Queue, No Buyers in Sight

2026-05-11 11:00:11

At Rs 28.41, sellers were still queuing — but there were no buyers willing to take the other side. Balaxi Pharmaceuticals Ltd locked at its lower circuit of 5% on 11 May 2026, with unfilled sell orders and a frozen price.

Read full news article

Balaxi Pharmaceuticals Ltd is Rated Sell

2026-05-10 10:10:37

Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Balaxi Pharmaceuticals Ltd Locks at Upper Circuit With 3.6% Gain — Buyers Queue, Sellers Absent

2026-05-07 11:00:12

At Rs 28.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Balaxi Pharmaceuticals Ltd locked at its upper circuit of 3.6% on 7 May 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Balaxi Pharmaceuticals Ltd is Rated Sell

2026-04-29 10:10:53

Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Balaxi Pharmaceuticals Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent

2026-04-21 14:00:08

At Rs 28.00, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Balaxi Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 21 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Balaxi Pharmaceuticals Ltd is Rated Sell

2026-04-18 10:10:38

Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 April 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Balaxi Pharmaceuticals Ltd is Rated Sell

2026-04-07 10:10:45

Balaxi Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Balaxi Pharmaceuticals Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent

2026-04-01 12:00:13

At Rs 18.80, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Balaxi Pharmaceuticals Ltd locked at its upper circuit of 19.97% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News